Instead of this wishy washy Smart CRC initiative (which who knows what that really is), I would have liked to see the Aussie govt support good innovation like ours, by giving our DFU treatment provisional approval - under strict scrutiny of course. This revolutionary wound treatment is too good to just let it pass by. Besides if some foreign company takes over Cyp at some point, Australians may never benefit from the wound healing innovation, as the treatment won’t be made available here as a priority.
CYP Price at posting:
20.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)